Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Cervical Cancer

  Free Subscription

Articles published in Br J Cancer

Retrieve available abstracts of 30 articles:
HTML format

Single Articles

    May 2024
  1. REBOLJ M, Brentnall AR, Cuschieri K
    Predictable changes in the accuracy of human papillomavirus tests after vaccination: review with implications for performance monitoring in cervical screening.
    Br J Cancer. 2024;130:1733-1743.
    PubMed     Abstract available

    April 2024
  2. PORTNOY A, Pedersen K, Kim JJ, Burger EA, et al
    Vaccination and screening strategies to accelerate cervical cancer elimination in Norway: a model-based analysis.
    Br J Cancer. 2024 Apr 20. doi: 10.1038/s41416-024-02682.
    PubMed     Abstract available

    January 2024
  3. WANG Y, He M, He T, Ouyang X, et al
    Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers.
    Br J Cancer. 2024 Jan 22. doi: 10.1038/s41416-023-02555.
    PubMed     Abstract available

    November 2023
  4. DOWNHAM L, Jaafar I, Rol ML, Nyawira Nyaga V, et al
    Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis.
    Br J Cancer. 2023 Nov 16. doi: 10.1038/s41416-023-02490.
    PubMed     Abstract available

    August 2023
  5. CUSCHIERI K, Palmer T, Graham C, Cameron R, et al
    The changing nature of HPV associated with high grade cervical lesions in vaccinated populations, a retrospective study of over 1700 cases in Scotland.
    Br J Cancer. 2023 Aug 10. doi: 10.1038/s41416-023-02386.
    PubMed     Abstract available

    July 2023
  6. KERRISON RS, Jones A, Peng J, Price G, et al
    Inequalities in cancer screening participation between adults with and without severe mental illness: results from a cross-sectional analysis of primary care data on English Screening Programmes.
    Br J Cancer. 2023;129:81-93.
    PubMed     Abstract available

    April 2023
  7. VERHOEF L, Bleeker MCG, Polman N, Steenbergen RDM, et al
    Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening.
    Br J Cancer. 2023 Apr 26:1-8. doi: 10.1038/s41416-023-02277.
    PubMed     Abstract available

  8. KAMAL M, Lameiras S, Deloger M, Morel A, et al
    Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.
    Br J Cancer. 2023 Apr 13. doi: 10.1038/s41416-023-02261.

    March 2023
  9. MITTELSTADT S, Kelemen O, Admard J, Gschwind A, et al
    Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapse.
    Br J Cancer. 2023 Mar 27. doi: 10.1038/s41416-023-02233.
    PubMed     Abstract available

  10. GILHAM C, Sargent A, Crosbie EJ, Peto J, et al
    Long-term risks of invasive cervical cancer following HPV infection: follow-up of two screening cohorts in Manchester.
    Br J Cancer. 2023 Mar 23. doi: 10.1038/s41416-023-02227.
    PubMed     Abstract available

    December 2022
  11. COSTA S, Verberckmoes B, Castle PE, Arbyn M, et al
    Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening.
    Br J Cancer. 2022 Dec 14. doi: 10.1038/s41416-022-02094.
    PubMed     Abstract available

    August 2022
  12. AASBO G, Trope A, Nygard M, Christiansen IK, et al
    HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial.
    Br J Cancer. 2022 Aug 23. pii: 10.1038/s41416-022-01954.
    PubMed     Abstract available

    June 2022
  13. HERBST J, Pantel K, Effenberger K, Wikman H, et al
    Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions.
    Br J Cancer. 2022 Jun 20. pii: 10.1038/s41416-022-01868.
    PubMed     Abstract available

    March 2022
  14. REBOLJ M, Pesola F, Mathews C, Mesher D, et al
    The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot.
    Br J Cancer. 2022 Mar 26. pii: 10.1038/s41416-022-01791.
    PubMed     Abstract available

    November 2021
  15. DICK S, Vink FJ, Heideman DAM, Lissenberg-Witte BI, et al
    Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping.
    Br J Cancer. 2021 Nov 6. pii: 10.1038/s41416-021-01614.
    PubMed     Abstract available

    September 2021
  16. IDEN M, Tsaih SW, Huang YW, Liu P, et al
    Multi-omics mapping of human papillomavirus integration sites illuminates novel cervical cancer target genes.
    Br J Cancer. 2021 Sep 15. pii: 10.1038/s41416-021-01545.
    PubMed     Abstract available

    April 2021
  17. BIZZARRI N, Pedone Anchora L, Zannoni GF, Carbone V, et al
    Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study.
    Br J Cancer. 2021 Apr 14. pii: 10.1038/s41416-021-01384.
    PubMed     Abstract available

  18. KREGTING LM, Kaljouw S, de Jonge L, Jansen EEL, et al
    Effects of cancer screening restart strategies after COVID-19 disruption.
    Br J Cancer. 2021;124:1516-1523.
    PubMed     Abstract available

    March 2021
  19. HALLE MK, Sodal M, Forsse D, Engerud H, et al
    A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease.
    Br J Cancer. 2021 Mar 15. pii: 10.1038/s41416-021-01305.
    PubMed     Abstract available

  20. EINBOND LS, Zhou J, Wu HA, Mbazor E, et al
    A novel cancer preventative botanical mixture, TriCurin, inhibits viral transcripts and the growth of W12 cervical cells harbouring extrachromosomal or integrated HPV16 DNA.
    Br J Cancer. 2021;124:901-913.
    PubMed     Abstract available

    February 2021
  21. CASTANON A, Rebolj M, Pesola F, Sasieni P, et al
    Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses.
    Br J Cancer. 2021 Feb 9. pii: 10.1038/s41416-021-01275.
    PubMed     Abstract available

  22. LITWIN TR, Irvin SR, Chornock RL, Sahasrabuddhe VV, et al
    Infiltrating T-cell markers in cervical carcinogenesis: a systematic review and meta-analysis.
    Br J Cancer. 2021;124:831-841.
    PubMed     Abstract available

    December 2020
  23. CIBULA D, Slama J, Dostalek L, Fischerova D, et al
    Tumour-free distance: a novel prognostic marker in patients with early-stage cervical cancer treated by primary surgery.
    Br J Cancer. 2020 Dec 14. pii: 10.1038/s41416-020-01204.
    PubMed     Abstract available

    November 2020
  24. KAMAL M, Lameiras S, Deloger M, Morel A, et al
    Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.
    Br J Cancer. 2020 Nov 16. pii: 10.1038/s41416-020-01153.
    PubMed     Abstract available

    October 2020
  25. ZHANG Y, Yu M, Jing Y, Cheng J, et al
    Baseline immunity and impact of chemotherapy on immune microenvironment in cervical cancer.
    Br J Cancer. 2020 Oct 22. pii: 10.1038/s41416-020-01123.
    PubMed     Abstract available

  26. ARROYO MUHR LS, Lagheden C, Lei J, Eklund C, et al
    Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR.
    Br J Cancer. 2020 Oct 6. pii: 10.1038/s41416-020-01111.
    PubMed     Abstract available

    September 2020
  27. MO XT, Leung TH, Tang HW, Siu MK, et al
    CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma.
    Br J Cancer. 2020;123:833-843.
    PubMed     Abstract available

    August 2020
  28. KYRGIOU M, Arbyn M, Bergeron C, Bosch FX, et al
    Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC).
    Br J Cancer. 2020;123:510-517.
    PubMed     Abstract available

    May 2020
  29. LEI J, Ploner A, Lehtinen M, Sparen P, et al
    Impact of HPV vaccination on cervical screening performance: a population-based cohort study.
    Br J Cancer. 2020 May 4. pii: 10.1038/s41416-020-0850.
    PubMed     Abstract available

    April 2020
  30. ARBYN M, Rezhake R, Yuill S, Canfell K, et al
    Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence.
    Br J Cancer. 2020 Apr 3. pii: 10.1038/s41416-020-0787.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.